The page of BIOCON. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 25-11-2024 is predicted based on technical analysis and should only be used as reference for learning purpose only.
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Biocon | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Windlas Biotech | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
| Company | LTP | Change | Gain |
|---|---|---|---|
| State-Bank-of-India | 816.05 | 35.3 | 4.52 % |
| Tata-Consultancy-Services-Limited | 4244.6001 | 171.75 | 4.22 % |
| Company | LTP | Change | Loss |
|---|---|---|---|
| HDFC-Bank | 1745.6 | 4.4 | 0.25 % |
| Axis-Bank-Limited | 1142.4 | 3.25 | 0.29 % |
